Clinical Liver Disease

NASH-related cirrhosis is the third most common indication for transplantation in the current era and accounts for 10% to 13% of transplants performed. The need for liver transplantation in patients with NAFLD is growing. Dr. Watt explains the impact of disease recurrence on short- and medium-term survival and addresses management approaches necessary to improve long-term survival.